Mobia Medical Q3 revenue rises 73% to $15.6 million; raises 2026 revenue outlook
Mobia Medical reported third quarter 2026 revenue of $15.6 million, up 73% from $9.0 million a year earlier, and raised its full year 2026 revenue guidance to $57.0 million to $57.5 million. The net loss widened to $17.3 million from $11.4 million, although the per-share loss narrowed to $0.52 from $13.31 after the company's IPO increased its share count.
Key points
- Q3 2026 revenue was $15.6 million, up from $9.0 million in Q3 2025; gross margin was 83.2% versus 79.6%.
- Net loss was $17.3 million in Q3 2026, compared with $11.4 million in Q3 2025; operating expenses rose 71% to $31.5 million.
- Full year 2026 revenue guidance was raised to $57.0 million to $57.5 million, from $54.0 million to $56.0 million previously.
- Cash and cash equivalents totaled $160.7 million as of September 30, 2026.
The filing
Written by AI on Nov 9, 2026, 10:08 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.